News
Trump could clean house at health agencies
November 11, 2020
Most of the president’s ire has been directed at Fauci. As far back as April, Trump retweeted a call for Fauci’s firing.
![1]()
Opinion
Hospitalist Medicare payments are at risk for large cuts in 2021
November 11, 2020
Medicare has proposed changes that would create unprecedented financial hardship for hospital medicine groups.
News
Supreme Court Justices seem skeptical of case to overturn ACA
November 10, 2020
It’s unlikely the Justices will issue a decision immediately. They have until the end of the term in June to rule.
![1]()
News
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
November 10, 2020
“We have supplies to distribute now. Product distribution will begin this week.”
News
New eGFR equation ‘less biased’ by age, kidney function; some disagree
November 10, 2020
The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and kidney function," according to its developers.
News
Great Barrington coauthor backs off strict reliance on herd immunity
November 10, 2020
The Great Barrington approach advocates isolation and protection of people who are most vulnerable to COVID-19 while avoiding what they characterize as lockdowns.
![1]()
News
United States adds nearly 74,000 more children with COVID-19
November 10, 2020
New weekly high in pediatric cases seen for the second consecutive week.
![1]()
News
No link shown between thyroid dysfunction and heart failure
November 10, 2020
Analysis of nearly 5,000 English heart failure patients showed no significant link between thyroid dysfunction and survival.
News
Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?
November 10, 2020
Environmental pollution during the COVID-19 pandemic puts dolphins, whales, seals, and otters among the sea mammals at risk.
News
Pfizer vaccine data show 90% efficacy in early results
November 9, 2020
BTN162b2, a messenger RNA–based vaccine candidate that requires two doses, is being developed by Pfizer and BioNTech SE.
